UNITED STATES OF AMERICA, Petitioner, v. ARTHREX, INC. ET AL., Respondents. Case No. 19-1434, 19-1452, amicus brief filed 12/2/2020.
The American Intellectual Property Law Association filed a consolidated amicus brief in support of reversal with the Supreme Court today in United States of America v. Arthrex, Inc. et al., Smith & Nephew, Inc., et al. v. Arthrex, Inc., et al., and Arthrex, Inc. v. Smith & Nephew, Inc., et al., Case Nos. 19-1434, 19-1452, and 19-1458, respectively, regarding the appointment of Administrative Patent Judges (APJs) under the Appointments Clause of Article II of the U.S. Constitution. In the case below, the Federal Circuit determined that APJs are unconstitutionally appointed principal officers based on the application of a three-factor test. AIPLA’s brief supports reversal of the Federal Circuit’s decision and argues that Supreme Court precedent does not support such a rigid, factor-specific approach, instead favoring a flexible analysis to assess whether an officer is “principal” or “inferior.” The brief explains that, while the question is a close one, the totality of the circumstances under this flexible approach supports finding that APJs are inferior officers who are constitutionally appointed.
The brief also notes that reversal would moot the need for any remedy and provide the least disruption to the patent system as a whole. The brief explains that the Federal Circuit’s chosen remedy – severing application of Title 5’s federal employment removal protections to APJs and ordering the rehearing of each affected case before a new panel – risks creating significant uncertainty, delay, and lack of transparency and accountability in the patent system, which would be contrary to Congress’ intent in establishing the role of APJs and the Patent Trial and Appeal Board.
Upcoming Events
-
2026 Patent Prosecution Bootcamp - Arlington, VA
March 4 to 6, 2026 | Up to 1235 minutes, including 60 Ethics minutes
-
2026 Trade Secret Summit
April 23 to 24, 2026
-
2026 Advanced Chemical & Biotech Patent Institute
May 11 to 12, 2026 | CLE calculations pending
The Advanced Chemical & Biotech Patent Institute is an in-depth continuing legal education program tailored specifically for experienced patent practitioners in the chemical and biotech fields. This advanced course offers a comprehensive view from both prosecution and litigation perspectives, covering crucial topics relevant to practice in the U.S. and internationally. -
2026 Spring Meeting - San Francisco, CA
May 13 to 15, 2026
We’re excited to welcome you to the 2026 AIPLA Spring Meeting, where innovation, technology, and intellectual property come together to shape the future. San Francisco is ready for your ideas, energy, and passion for IP! -
AIPLA 2026 Annual Meeting
October 29 to 31, 2026
Join us as we bring IP professionals together to learn and connect. More information coming soon! The 2026 Annual meeting will take place at the Westin Washington, DC, Downtown. Leadership Meetings on Wednesday, October 28. Programming scheduled October 29 - 31.
